4:51 PM ET Biogen delivered a "solid" quarterly beat as its multiple sclerosis treatment sales stabilize, but shares were hamstrung on pipeline bumbles....

4:51 PM ET Biogen delivered a "solid" quarterly beat as its multiple sclerosis...